Company / Current Liabilities
IQVIA Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$8.3B
FY2025
5-year range
$5.2B / $8.3B
FY2021-FY2025
Trend
+19.9%
vs FY2024
Sector context
#14 of 160
Health Care
What the data says
Among 160 Health Care companies, IQVIA is in the bottom 9% for current liabilities. Current Liabilities has increased for 9 consecutive years, from $2.7B in FY2016 to $8.3B in FY2025.
Based on SEC 10-K filings.
$8.3B in FY2025 with a 5-year CAGR of +12.8%. Top quartile in the Health Care sector.
Increased from $6.5B to $8.3B over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +14.3%
- 5-Year CAGR
- +12.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 160This company $8.3B Sector average $4.5B
▼
+86.2% above sector average
Key checks
Key Insights
- IQVIA's current liabilities has grown for 9 consecutive years.
- 5-year CAGR of +12.8%, indicating consistent growth.
- In FY2025, current liabilities increased 19.9% year-over-year.
- Ranks #14 out of 160 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 20.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.3B | +19.9% |
| FY2024 | $7.0B | +7.2% |
| FY2023 | $6.5B | +16.4% |
| FY2022 | $5.6B | +6.4% |
| FY2021 | $5.2B | +15.0% |
| FY2020 | $4.6B | +15.5% |
| FY2019 | $3.9B | +11.6% |
| FY2018 | $3.5B | +12.0% |
| FY2017 | $3.2B | +16.7% |
| FY2016 | $2.7B | +69.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026